Nagraniezekranu2024-12-17o12.28.55-ezgif.com-crop
Loading ...

EMPOWERING MEDICAL PROGRESS

CLINICAL TRIALS

DATA SCIENCE

We implement innovative research models based on modern technologies to provide patients with access to valuable medical solutions.
By conducting clinical trials, we build reliable knowledge about pharmaceutical products and medical devices.

Card Image

Your trusted partner in research

Scientia is a trusted partner for comprehensive research services. We combine expertise in the medical field with years of experience in conducting and overseeing both commercial and non-commercial research, in adult and juvenile populations.

Our experience includes more than 50 projects in various areas of the critical therapeutic field, 30% of which are pediatric studies.

The team of experts is committed to patient safety, reliability and the highest quality of research, implementing projects tailored to the needs of Our Partner.

Cardiology

Rare disease

ATMP

CAR-T – CAR-NK

Telemedicine

AI

Experience

50+

Studies

150+

Active centers

Scientia is a Contract Research Organization (CRO) covering the whole of Poland and working with partners from Europe and the USA.

Therapeutic areas

Oncology

Hematology

Endocrinology

Cardiology

Pulmunology

Gastroenterology

Diabetology

Otolaryngology

Neurology

Gynecology

Nepherology

Pediatrics

Key projects


Comprehensive clinical research projects for the future of medicine.

Our projects cover all stages of clinical trials, from early phases to advanced stages of drug or medical product development, providing valuable data that supports the development of new therapies and innovative medical solutions. We conduct experimental and observational projects across various therapeutic areas. Discover our capabilities in a groundbreaking and innovative approach to science.

Breakthrough research concepts, such as the ELECTRA SIRIO 2, have the potential to significantly improve the safety and effectiveness of ss of standard, well established treatment regimens.

Personalized medical approaches – research on therapies tailored to the individual genetic characteristics of patients, such as CAR-T and CAR-NK therapies.

New uses for registered drugs (discovering new therapeutic indications for already approved molecules), e.g., MGCDB001.

Innovative ATMP therapies that have not been previously clinically tested, e.g., FOOTCELL.

Innovative treatment methods using AI technologies, e.g., PRINTGRAF.

Out of the box methodological approaches using telemedicine solutions, e.g., SMART.

New medical technologies e.g., cardioneuroablation, TELE-SPACER, Gentle Pace.

CAR-T therapy (Chimeric Antigen Receptor T-cell Therapy) is an advanced method of treating cancer, particularly those that are difficult to address with traditional methods such as chemotherapy or radiotherapy. Thanks to genetically modifying the patient’s T lymphocytes (immune system cells), it becomes possible to precisely recognize and destroy cancer cells.

We collaborate with biotechnology companies and academic institutions on the development of CAR-T therapy treatment methods.

Card Image

Values

We act responsibly

In our daily work, we follow the fundamental values that are key to the progress of science.

Ethics and integrity

Ethics and integrity are the foundations of SCIENTIA’s operations. We adhere to the principles of integrity, ensure transparency in research processes, and ensure that all activities are in compliance with the standards and regulations applicable in the R&D area.

Innovative Services

Successfully conducting a research project requires the sponsor to have an efficient organizational structure, practical procedures and systems, knowledge of regulations applicable in clinical trials, and experience in planning and managing research projects. We support our partners in each of these areas.

We are a company offering comprehensive services for organizing research projects – we have implemented the requirements of ICH GCP E6 (R3) and E8. We base our work on the European Medicines Agency and the FDA standards. We apply modern research models and quality design strategies to our planned projects. Our projects are conducted with diverse participant groups in critical therapeutic areas. There are many challenges in these projects, and ensuring ongoing monitoring and continuous analysis of risks and outcomes becomes crucial. This is exactly what we provide, allowing our projects to be carried out in a changing environment. We have a strong scientific background and are continuously developing IT tools to implement projects.

Card Image

Team

People for people – not only technology matters!

As a team, we understand the importance of progress in medicine, so we engage fully and wholeheartedly in each of our activities.

As a team, we understand the importance of progress in medicine, so we engage fully and wholeheartedly in each of our activities.

Our team members have carried out research in cooperation with medical universities and research institutes in Poland and abroad now share their knowledge as academic lecturers.

Our specialists ensure that clinical trials are conducted with the highest standards of quality, ethics, and applicable rules and regulations, which is necessary to obtain reliable results.

More than 40% of our staff are experts with a Ph.D. The team is also experienced in document management, contract processing and budget management for commercial and non-commercial projects. All employees hold current ICH-GCP Good Clinical Practice certificates.

Loading...

Medical Writing

Preparation of the documentation of clinical trials and research experiments, including protocols, study plans, investigator brochures, final reports and product safety assessments. Preparation of publications and posters to effectively present the obtained results. Creation and submission of applications (including creation of documentation) to obtain necessary permits. Communication with regulatory bodies and bioethics committees. Reporting modifications to protocols and other documents.